What are the two classification of leprosy?

Leprosy has traditionally been classified into two major types, tuberculoid and lepromatous. Patients with tuberculoid leprosy have limited disease and relatively few bacteria in the skin and nerves, while lepromatous patients have widespread disease and large numbers of bacteria.

What are the three types of leprosy?

The first system recognizes three types of Hansen’s disease: tuberculoid, lepromatous, and borderline. A person’s immune response to the disease determines which of these types of Hansen’s disease they have: In tuberculoid Hansen’s disease, the immune response is good.

Which antibiotics are for leprosy?

Hansen’s disease is treated with a combination of antibiotics. Typically, 2 or 3 antibiotics are used at the same time. These are dapsone with rifampicin, and clofazimine is added for some types of the disease. This is called multidrug therapy.

How can you distinguish between Multibacillary and Paucibacillary leprosy?

Paucibacillary single lesion leprosy: 1 skin lesion. Paucibacillary leprosy: 2 to 5 patches or lesions on the skin. Multibacillary leprosy: >5 patches or lesions on the skin. Individual patient records at peripheral level for investigation and case-management.

Who is Ridley Jopling?

Ridley proposed the Ridley-Jopling classification of leprosy (1962), and wrote the widely read textbook of “Handbook of Leprosy” which had a fifth edition….

William Jopling
Known for	Ridley-Jopling classification of leprosy, Textbook Handbook of Leprosy and medical papers including leprosy stigma

What are the 3 main symptoms of leprosy?

The three main symptoms of leprosy include:

• Skin patches which may be red or have a loss of pigmentation.
• Skin patches with diminished or absent sensations.
• Numbness or tingling in your hands, feet, arms and legs.
• Painless wounds or burns on the hands and feet.
• Muscle weakness.

WHO leprosy guidelines?

The currently recommended MDT regimen consists of medicines: dapsone, rifampicin and clofazimine. This treatment lasts six months for pauci-bacillary and 12 months for multi-bacillary cases. MDT kills the pathogen and cures the patient. Since 1981 WHO has provided MDT free of cost.

What is the recommended standard treatment duration for leprosy?

The treatment duration was initially 24 months for MB patients, later reduced to 12 months in 1998. The treatment duration for PB patients has always been six months. Several countries, such as the USA, treat patients daily with rifampin.

Who Multibacillary and Paucibacillary?

Paucibacillary patients are those who are skin smear negative and show no evidence of more advanced disease on biopsy. Multibacillary patients are those who are skin smear positive and/or have a biopsy indicating more advanced disease.

What is BT in leprosy?

Borderline leprosy includes borderline tuberculoid (BT), borderline borderline (BB), and borderline lepromatous (BL) leprosy. Borderline tuberculoid leprosy patients have anesthetic discrete plaques similar to those in tuberculoid leprosy. However, there are multiple lesions, usually more than five and fewer than 10.

What is BB in leprosy?

Bacterial indices range from 0 to 2. In BB or mid-borderline leprosy, patients present with numerous asymmetrical annular plaques. The classic lesion of BB disease is the dimorphic lesion, which has features of both tuberculoid and lepromatous lesions.

Is there vaccine for leprosy?

There are two leprosy vaccine candidates, MIP in India (82) and LepVax (66), and the TB vaccine pipeline is much more advanced and diverse than the one for leprosy.

Why rifampicin is given once a month in leprosy?

To promote compliance and to move away from long-term monotherapy such as dapsone. To retain rifampicin in all therapeutic regimens because of its powerful bactericidal action and its effectiveness even when taken once a month. To promote compliance and cost effectiveness.

Why is rifampicin given only once a month in leprosy?

Why rifampicin is given monthly in leprosy?

Therefore newer drugs were considered and rifampicin was a logical choice because of its strong bactericidal effect against Mycobacterium leprae, the micro-organism causing leprosy.

WHO is Ridley Jopling?

WHO Paucibacillary leprosy treatment?

In 2018, the WHO recommended that all leprosy patients receive treatment with three drugs. The WHO regime is rifampicin 600 mg, clofazimine 300 mg, dapsone 100 mg once per month and dapsone 100 mg and clofazimine 50 mg daily on the other days (Table 83.2).

What is the Ridley-Jopling classification for leprosy?

Treatment regimens were originally assigned on the basis of the Ridley-Jopling classification [ 1 ], which defined I, TT, and BT cases of leprosy as being paucibacillary (PB), and BB, BL, and LL cases of leprosy as being multibacillary (MB).

What is the Ridley-Jopling classification of the disease?

The Ridley-Jopling classification of the disease is the one usually used in the United States. The following terms denote disease ranging from early localized (I) to generalized (LL):

Is the classification of leprosy patients for treatment purposes necessary?

Slit skin smears properly classified 91% and 97% of PB and MB patients, respectively. Based on U-MDT/CT-BR results, classification of leprosy patients for treatment purposes is unnecessary because it does not impact clinical and laboratories outcomes.

How many leprosy patients were included in the U-MDT/CT-BR study?

Methods Study groups. This is a cross-sectional descriptive study that used the database of the U-MDT/CT-BR at baseline. Originally, 859 newly diagnosed, previously untreated PB and MB leprosy patients were included.